Prof. Antoine Roquilly, coordinator of Homi-Lung, took part in ISICEM 2026 in Brussels. He contributed to 3 scientific sessions on sepsis, multi-omic subphenotyping and the respiratory microbiome, and served as poster jury member.
#Pneumonia #CriticalCare #Microbiome #ISICEM2026
Prof. Antoine Roquilly will speak at an ERS Respiratory Channel webinar organised by the Institut Pasteur in Lille on 29 April 2026.
Title: “Personalised non-antimicrobial therapy for severe pneumonia".
REGISTER NOW: channel.ersnet.org/media-121379...
#Pneumonia #Microbiome #PrecisionMedicine
Reviewers highlight excellent progress: core clinical studies (CAP, HAP, Healthy Lung) launched, ethics/regulatory approvals completed, and recruitment underway across multiple European sites.
We thank contributors, inside and outside the consortium, for their continued commitment and dedication.
Homi-Lung has successfully completed its first Horizon Europe project review, with the Commission confirming the project implementation is satisfactory and backed by very positive expert feedback.
Read more: homilung.com/homi-lung-re...
The programme addresses key topics such as pneumonia endotypes, immune dysregulation, the role of macrolides, and host–microbiome interactions, reflecting a shared commitment to disseminating state-of-the-art research to the wider scientific community.
🔗 focisnet.org/education/vi...
Today, @focisimmunology.bsky.social is hosting a virtual symposium on host–respiratory microbiome dynamics for new pneumonia treatments (15:00–17:00 Paris time).
The session, led by Antoine Roquilly @univ-nantes.fr, brings together Homi-Lung consortium members from across Europe and beyond!
✨Our team wishes you a very Happy New Year!
We look forward to another year of collaboration and scientific progress, working together to improve health and quality of life.
homilung.com
Patients who developed VAP showed higher TNF-α levels and metabolic profiles suggesting a shift to anaerobic metabolism, pointing to early immune–metabolic signatures of infection.
Read more: homilung.com/study-reveal...
A study in Critical Care followed 80 critically ill patients under invasive mechanical ventilation (VAP) to understand how lung microbiome, immunity and metabolism evolve.
It was led by Ingrid G. Bustos and colleagues, including Homi-Lung partner Robert P. Dickson from @umich.edu.
1 in 3 cases of hospital-acquired pneumonia still fail treatment.
A recent study, led by @chunantes.bsky.social and Homi-Lung partners, identifies 2 clinical subphenotypes and a practical bedside score (PHOENYCS) to guide personalised care.
homilung.com/new-phenotyp...
#PrecisionMedicine #ICU
We’re excited to work on understanding host-microbiome interactions to create more effective treatments after pneumonia. Follow us for updates on how Homi-Lung is making a difference in cardiovascular and respiratory care.
🌐 homilung.com #HealthInnovation
Coordinated from Nantes Université, the Homi-Lung Consortium includes hospitals, universities, and biotech companies working together to develop new diagnostic tools. Collaboration is key to solving complex health challenges. #ResearchCollaboration
The Homi-Lung project is a groundbreaking 5-year initiative aiming to understand the link between pneumonia and cardiovascular diseases. Funded by the EU’s Horizon Europe, it brings together experts from Europe and beyond. #HorizonEurope
